Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.

Emiliano CalviNicola BernardiGiuliana CiminoGreta PascarielloPompilio FaggianoEmanuele GavazziEnrico VizzardiMarco Metra

Published in: European heart journal. Case reports (2020)

This evidence confirms that COVID-19 induces a hypercoagulable state which can result in intracardiac thrombosis. Therefore, TTE is indicated in all COVID-19 patients for early diagnosis, and prompt anticoagulant therapy is to be considered as a thromboprophylaxis strategy.

Keyphrases

coronavirus disease
sars cov
pulmonary embolism
venous thromboembolism
respiratory syndrome coronavirus
left atrial appendage
atrial fibrillation
direct oral anticoagulants
stem cells
mesenchymal stem cells